Q&A: Dr. Mary-Ann Etiebet, Executive Director, Merck for Mothers

Posted on Fri/8/MayFri/8/May by AZBio

With Mother’s Day just around the corner, BIO sat down with Dr. Mary-Ann Etiebet, Executive Director of Merck for Mothers, for a discussion about how Merck helping address maternal health needs in the United States and in countries impacted by COVID-19. Continue reading→

Health Catalysts Group publishes The Diagnostics Year in Review

Posted on Fri/8/MayFri/8/May by AZBio

Led by diagnostics industry veteran Mara G. Aspinall, Health Catalysts Group is an Arizona based consulting and informatics firm focused on the success of life sciences companies.

Continue reading→

Treating COVID-19 Patients With Acute Heart Failure

Posted on Tue/5/MayTue/5/May by AZBio

A paper published in two medical journals last week offers guidelines for physicians treating coronavirus patients requiring advanced life-saving therapies.Continue reading→

TGen and HonorHealth Initiate COVID-19 Combination Therapy of Atovaquone and Azithromycin

Posted on Tue/5/MayThu/7/May by AZBio

Established combination seen as safer option for coronavirus therapy; will add data to TGen COVID Immunity Study and virus sequencing effortsContinue reading→

USPTO Launches Patents 4 Partnerships

Posted on Tue/5/MayTue/5/May by AZBio

USPTO launches platform to facilitate connections between patent holders and potential licensees in key technologies. Initial release focuses on COVID-19–related technologiesContinue reading→

Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program

Posted on Tue/5/MayTue/5/May by AZBio

First participants dosed at NYU Grossman School of Medicine and University of Maryland School of Medicine
Pfizer and BioNTech ramping up manufacturing capabilities to further increase production capacity in 2020/2021

Continue reading→

UArizona Researchers Team Up to Address COVID-19 with the Help of TRIF and BIO5 Support

Posted on Mon/4/MaySat/9/May by AZBio

Research projects will address the pandemic from various angles, including public health, virology and drug discovery.
Continue reading→

AdvaMed Announces VentConnect Online Platform to Scale the Production and Distribution of Ventilators

Posted on Mon/4/MayMon/4/May by AZBio

New portal developed with the Aerospace Industries Association and Google connects ventilator component suppliers with manufacturersContinue reading→

Roche’s COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets accepting the CE mark

Posted on Mon/4/MayMon/4/May by AZBio

The serology test has a specificity greater than 99.8% and sensitivity of 100% (14 Days post-PCR confirmation)
The high specificity of the test is crucial to determine reliably if a person has been exposed to the virus and if the patient has developed antibodies
Roche will provide high double-digit millions of tests already in May for countries accepting the CE mark and in the U.S. under Emergency Use Authorization, further ramping up capacities thereafter
The test is available on Roche’s cobas e analysers which are widely available around the world

Continue reading→

COVID-19 Update #4 shared by an Arizona Emergency Physician and Legislator

Posted on Mon/4/MayMon/4/May by AZBio

Amish Shah, MD is an emergency physician at Dignity Health and a member of the Arizona House of Representative elected by the people of LD24 – Central Phoenix and South Scottsdale. On Sunday, May 3, 2020, Dr. Shah shared the message below via Facebook. With his permission, we are sharing it with you. Continue reading→